Recent advances in chemical proteomics for protein profiling and targeted degradation. [PDF]
Liu PK, Wang Z, Li L.
europepmc +1 more source
Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions. [PDF]
Banerjee S, Adhikari N, Ghosh B.
europepmc +1 more source
PROTACs in cancer immunotherapy: a minireview. [PDF]
J E K, E S CA, E T C, J S G, F M F.
europepmc +1 more source
Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC Discovery. [PDF]
Mitrović M +19 more
europepmc +1 more source
PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. [PDF]
Syahputra EW +5 more
europepmc +1 more source
Development and Evaluation of Liposomal <i>Celastrol</i>-PROTACs for Treating Triple-Negative Breast Cancer. [PDF]
Li X +5 more
europepmc +1 more source
Tumor microenvironment-targeted PROTAC nanoparticle self-assembly broadly predicted by structural descriptors. [PDF]
Vogt KC +12 more
europepmc +1 more source
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy. [PDF]
Shi J +8 more
europepmc +1 more source
Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy. [PDF]
Rivault A +6 more
europepmc +1 more source

